FSC Wealth Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$18.7M |
| 2 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$16.8M |
| 3 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$10.4M |
| 4 |
Apple
AAPL
|
+$728K |
| 5 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$412K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$499K |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$71K |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$71K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$50.3K |
| 5 |
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
|
+$47K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.32% |
| 2 | Healthcare | 3.1% |
| 3 | Communication Services | 1.39% |
| 4 | Financials | 1.14% |
| 5 | Consumer Discretionary | 0.85% |
Similar funds
FSC Wealth Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, FSC Wealth Advisors held 224 positions worth $58.5M, up 463% from $10.4M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
FSC Wealth Advisors deployed $47.7M of net new capital in Q4 2022, opening 18 new positions and adding to 34 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 203,887 shares worth $18.6M.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 23% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Vanguard Intermediate-Term Treasury ETF, an estimated $50.3K trimmed.
- FSC Wealth Advisors's largest Q4 2022 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 203,887 shares worth $18.6M.
- FSC Wealth Advisors added most to Apple in Q4 2022, an estimated $728K increase.
- FSC Wealth Advisors's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $50.3K.
- FSC Wealth Advisors fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $499K.
- FSC Wealth Advisors's ten largest holdings make up 88% of its $58.5M portfolio in Q4 2022.
- FSC Wealth Advisors opened 18 new positions and closed 67 in Q4 2022.
- FSC Wealth Advisors's portfolio value rose 463% quarter-over-quarter to $58.5M.
Based on FSC Wealth Advisors's 13F filing for Q4 2022, filed 17 Jan 2023.